{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:14:21Z","timestamp":1778181261401,"version":"3.51.4"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,11,17]],"date-time":"2013-11-17T00:00:00Z","timestamp":1384646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Allergy Immunology"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Vernal keratoconjunctivitis (<jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content>) is a chronic disease affecting conjunctiva even though the immunopathogenetic mechanisms underlying this inflammation are unclear. The aim of our study is to investigate serum levels of <jats:styled-content style=\"fixed-case\">HMGB<\/jats:styled-content>1 and circulating <jats:styled-content style=\"fixed-case\">sRAGE<\/jats:styled-content> in children affected by <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content> before and after treatment with cyclosporine <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>s<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>) eye drops and in a group of healthy children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty\u2010four children affected by <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content> aged between 5 and 12\u00a0yrs of life were enrolled at the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>epartment of <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ediatrics, <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ivision of <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>llergy and <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>mmunology, \u2018<jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>apienza\u2019 <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>niversity of <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>ome. Twenty\u2010four healthy children without atopy, ocular, and systemic disease, cross\u2010matched for sex and age to patients affected by <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content>, represented the controls. All children affected by <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content> were treated with <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>s<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> 1% eye drops for 4\u00a0wks, and blood samples were collected before and 2\u00a0wks after the end of treatment while the controls underwent to a single blood sample at the time of enrollment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum basal levels of <jats:styled-content style=\"fixed-case\">HMGB<\/jats:styled-content>1 and <jats:styled-content style=\"fixed-case\">sRAGE<\/jats:styled-content> were higher in children with <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content> when compared with controls while, in patients affected by <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content>, no difference was detected between atopic and non\u2010atopic, and between <jats:styled-content style=\"fixed-case\">ANA<\/jats:styled-content>\u2010positive and <jats:styled-content style=\"fixed-case\">ANA<\/jats:styled-content>\u2010negative children. A significant reduction in serum <jats:styled-content style=\"fixed-case\">HMGB<\/jats:styled-content>1 and <jats:styled-content style=\"fixed-case\">sRAGE<\/jats:styled-content> levels was detected after the therapy while <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>s<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> serum levels were negative.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study gives a support to the definition of <jats:styled-content style=\"fixed-case\">VKC<\/jats:styled-content> as a systemic inflammation in which <jats:styled-content style=\"fixed-case\">HMGB<\/jats:styled-content>1 and its soluble receptors could play a role.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pai.12142","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T06:05:39Z","timestamp":1384754739000},"page":"57-63","source":"Crossref","is-referenced-by-count":25,"title":["High\u2010mobility group box\u20101 (<scp>HMGB<\/scp>\u20101) and serum soluble receptor for advanced glycation end products (<scp>sRAGE<\/scp>) in children affected by vernal keratoconjunctivitis"],"prefix":"10.1111","volume":"25","author":[{"given":"Anna Maria","family":"Zicari","sequence":"first","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Zicari","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Nebbioso","sequence":"additional","affiliation":[{"name":"Department of Sense Organs \u2018Sapienza\u2019 University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Mari","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Celani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Lollobrigida","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azzurra Cesoni","family":"Marcelli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Occasi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Duse","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u2018Sapienza\u2019 University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,17]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00092-0"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301376"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00427.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200424916"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132603"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.248"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200114002"},{"key":"e_1_2_7_9_1","first-page":"294","article-title":"Plasma soluble receptor for advanced glycation end\u2010products and risk of colorectal adenoma","volume":"3","author":"Jiao L","year":"2012","journal-title":"Int J Mol Epidemiol Genet"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.223438"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345246"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.10.016"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.08.016"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.03998.x"},{"key":"e_1_2_7_15_1","first-page":"19","article-title":"Supra\u2010tarsal injection of dexamethasone in the treatment of patients with refractory vernal keratoconjunctivitis","volume":"41","author":"Lisanework M","year":"2003","journal-title":"Ethiop Med J"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00089-0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2009.00948.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2012.01281.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00570.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03626.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00295-0"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680490516738"},{"key":"e_1_2_7_23_1","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis","volume":"40","author":"Hingorani M","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep199"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.06.031"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3124"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.590463"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.041"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2003.01538.x"}],"container-title":["Pediatric Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpai.12142","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.12142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T23:50:32Z","timestamp":1696463432000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pai.12142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1111\/pai.12142"],"URL":"https:\/\/doi.org\/10.1111\/pai.12142","archive":["Portico"],"relation":{},"ISSN":["0905-6157","1399-3038"],"issn-type":[{"value":"0905-6157","type":"print"},{"value":"1399-3038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,17]]}}}